- Conditions: Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain Tumor
Interventions: Drug: aminolevulinic acid; Procedure: therapeutic conventional surgery
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Not yet recruiting - verified April 2012 - Conditions: Basal Cell Nevus Syndrome; Gorlin's Syndrome
Interventions: Drug: GDC-0449; Procedure: Aminolevulinic acid %20 topical solution + blue light
Sponsors: Children's Hospital & Research Center Oakland; Children's Hospital & Research Center Oakland; Genentech
Not yet recruiting - verified March 2012 - Conditions: Acute Porphyrias; Cutaneous Porphyrias
Intervention:
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine
Recruiting - verified March 2012 - Condition: Colon Cancer
Intervention: Drug: PDT with 5-ALA radiosensitization
Sponsors: Holcombe, Randall F., M.D.; Holcombe, Randall F., M.D.; University of California, Irvine; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Combination Therapy With 5-FU and PDT for the Treatment of Post-transplant Premalignant Skin DiseaseConditions: Actinic Keratosis; Solid Organ Transplant With Actinic Keratosis
Intervention: Drug: 5-Fluorouracil
Sponsors: The Cleveland Clinic; The Cleveland Clinic; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Insomnia; Nocturnal Awakening; Irritability; Coping Behavior; Stress
Interventions: Dietary Supplement: 5-Aminolevulinic Acid (5-ALA); Dietary Supplement: Placebo
Sponsors: University of Hawaii; University of Hawaii; SBI ALApromo Co., Ltd. - Strategic Business Innovator
Recruiting - verified February 2012 - Conditions: Astrocytoma; Glioma
Intervention: Drug: 5-Aminolevulinic Acid
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting - verified December 2011 - Condition: Glioma
Intervention: Drug: 5-Aminolevulinic acid (ALA) or ascorbic acid (placebo)
Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; St. Joseph's Hospital and Medical Center, Phoenix
Recruiting - verified January 2012 - Condition: Actinic Keratosis
Interventions: Drug: Broad Area ALA 1-hour incubation; Drug: Broad Area ALA 2-hr incubation; Drug: broad area ALA 3-hour incubation; Drug: Spot application ALA 2 hour incubation; Drug: Vehicle PDT
Sponsors: DUSA Pharmaceuticals, Inc.; DUSA Pharmaceuticals, Inc.
Recruiting - verified February 2012 - Condition: Keratosis, Actinic
Interventions: Drug: Aminolevulinic Acid PDT (ALA); Drug: Vehicle PDT (VEH)
Sponsors: DUSA Pharmaceuticals, Inc.; DUSA Pharmaceuticals, Inc.
Recruiting - verified November 2011 - Conditions: Benign Neoplasms, Brain; Brain Cancer; Brain Neoplasms, Benign; Brain Neoplasms, Malignant; Brain Tumor, Primary; Brain Tumor, Recurrent; Brain Tumors; Intracranial Neoplasms; Neoplasms, Brain; Neoplasms, Intracranial; Primary Brain Neoplasms; Primary Malignant Brain Neoplasms; Primary Malignant Brain Tumors; Gliomas; Glioblastoma
Intervention: Drug: 5-ALA (Gliolan)
Sponsors: Emory University; Emory University
Recruiting - verified April 2012 - Condition: Glioma
Intervention: Drug: 5-Aminolevuline Acid
Sponsors: Legacy Health System; Legacy Health System; DUSA Pharmaceuticals, Inc.
Recruiting - verified July 2011 - Conditions: Basal Cell Carcinoma of the Skin; Pain; Recurrent Skin Cancer
Interventions: Drug: methyl-5-aminolevulinate hydrochloride cream; Drug: photodynamic therapy; Procedure: laser therapy
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Actinic Keratosis
Interventions: Drug: Imiquimod/photodynamic therapy; Drug: Imiquimod only
Sponsors: Tennessee Clinical Research Center; Tennessee Clinical Research Center; Graceway Pharmaceuticals, LLC
Recruiting - verified July 2011 - Condition: Brain Neoplasms
Intervention: Drug: 5-aminolevulinic acid
Sponsors: Southern Illinois University; Southern Illinois University; Memorial Medical Center; DUSA Pharmaceuticals, Inc.
Recruiting - verified February 2012 - Condition: Glioma
Intervention: Drug: 5-Aminolevuline Acid
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Condition: Head and Neck Tumors
Intervention: Drug: Levulan
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified November 2011 - Conditions: Head and Neck Cancer; Precancerous Condition
Intervention: Drug: aminolevulinic acid hydrochloride
Sponsors: National Cancer Institute (NCI); Abramson Cancer Center of the University of Pennsylvania; National Cancer Institute (NCI)
Recruiting - verified September 2009 - Conditions: Primary Glial Neoplasms of Brain; Glioblastoma
Interventions: Drug: Aminolevulinic Acid; Drug: Aminolevulinic Acid
Sponsors: West Penn Allegheny Health System; West Penn Allegheny Health System; DUSA Pharmaceuticals, Inc.
Recruiting - verified February 2010 - Condition: Brain Tumors
Intervention: Drug: 5-aminolevulinic acid
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center
Recruiting - verified October 2011 - Condition: Brain and Central Nervous System Tumors
Intervention: Drug: aminolevulinic acid
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified February 2012
 |
Aminolevulinic Acid Clinical Trials |
